Bill > S3677

This bill, titled the "Dietary Supplement Listing Act of 2026," aims to increase transparency and information availability for dietary supplements by amending the Federal Food, Drug, and Cosmetic Act. It mandates that manufacturers, packers, or distributors of dietary supplements marketed in the United States, or their designated U.S. agents if they are foreign entities, must list each supplement with the Secretary of Health and Human Services. This listing, which can be submitted electronically, requires detailed information including the supplement's name, brand, all ingredients and their amounts per serving (with proprietary blend ingredient amounts kept confidential), daily values if applicable, the number of servings per container, directions for use, warnings, allergen statements, the form of the supplement (e.g., tablet, capsule), and any health-related claims made. The bill specifies deadlines for listing existing supplements and new ones introduced after a certain date, and requires notification of discontinued products and changes to existing listings. The Secretary will assign a product listing number to each supplement and, within two years of enactment, establish a publicly accessible electronic database containing most of this information, excluding certain confidential details. Failure to comply with these listing requirements will result in the dietary supplement being considered misbranded. The bill also includes provisions for authorized appropriations to fund these activities and prohibits the introduction of dietary supplements prepared with the assistance of individuals debarred under section 306 of the Act.

Health and Social Services

https://www.congress.gov/bill/119th-congress/senate-bill/3677/all-info